title: The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.
abstract: It has been proposed that changes in the composition of gut microbiota contribute to the development of diabetes Types 1, 2 and 3 (the latter known as Alzheimer's disease). The onset of these diseases is affected by complex interactions of genetic and several environmental factors. Alterations in gut microbiota in combination with specific diets can result in increased intestinal permeability leading via a continuous state of low-grade inflammation to the development of insulin resistance. Since a change in composition of gut microbiota is also suggested to be the underlying factor for the development of obesity, it is obvious to link gut microbiota with the pathogenesis of diabetes. In addition, insulin resistance in the brain has been recently associated with Alzheimer's disease. These new paradigms in combination with data from studies with prebiotics and probiotics may lead to a novel way to control and even prevent diabetes in general.
authors.affiliation: Department of Science, University College Roosevelt, Middelburg, The Netherlands.
authors.forename: Pjotr
authors.initials: P
authors.lastname: Bekkering
authors.forename: Ismael
authors.initials: I
authors.lastname: Jafri
authors.forename: Frans J
authors.initials: FJ
authors.lastname: van Overveld
authors.forename: Ger T
authors.initials: GT
authors.lastname: Rijkers
mesh_terms: D000544:Alzheimer Disease / Q000276:immunology* / Q000382:microbiology / Q000628:therapy; D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000382:microbiology / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000276:immunology* / Q000382:microbiology / Q000628:therapy; D059647:Gene-Environment Interaction; D006801:Humans; D018928:Immunity, Mucosal; D007333:Insulin Resistance / Q000276:immunology; D007422:Intestines / Q000276:immunology* / Q000382:microbiology; D064307:Microbiota / Q000276:immunology*; D009765:Obesity / Q000276:immunology* / Q000382:microbiology / Q000628:therapy; D019936:Probiotics / Q000627:therapeutic use